Denali Therapeutics DNLI
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 16.51 | 1,014 | -13.25 | -129 | -11.68 | 1,145 |
| 2025Q3 | 14.52 | 926 | -12.99 | -127 | -11.42 | 1,056 |
| 2025Q2 | 13.99 | 1,027 | -11.55 | -124 | -10.18 | 1,166 |
| 2025Q1 | 13.60 | 1,123 | -11.31 | -133 | -10.05 | 1,271 |
| 2024Q4 | 20.38 | 1,230 | -9.01 | -115 | -8.11 | 1,374 |
| 2024Q3 | 29.13 | 1,318 | -7.92 | -107 | -7.25 | 1,454 |
| 2024Q2 | 23.22 | 1,387 | -6.97 | -99 | -6.42 | 1,503 |
| 2024Q1 | 20.52 | 1,455 | -8.19 | -102 | -7.44 | 1,581 |
| 2023Q4 | 21.46 | 1,031 | -11.12 | -119 | -9.99 | 1,154 |
| 2023Q3 | 20.63 | 1,118 | -8.62 | -99 | -7.82 | 1,237 |
| 2023Q2 | 29.51 | 1,187 | 17.03 | 183 | 13.51 | 1,306 |
| 2023Q1 | 23.04 | 967 | -10.93 | -110 | -7.65 | 1,409 |
| 2022Q4 | 27.81 | 1,042 | -10.65 | -99 | -7.34 | 1,460 |
| 2022Q3 | 30.69 | 811 | -12.18 | -103 | -8.20 | 1,228 |
| 2022Q2 | 29.43 | 884 | -6.52 | -59 | -4.50 | 1,292 |
| 2022Q1 | 32.17 | 918 | -6.94 | -65 | -4.79 | 1,321 |
| 2021Q4 | 44.60 | 962 | -7.62 | -75 | -5.27 | 1,404 |
| 2021Q3 | 50.45 | 1,012 | -8.11 | -85 | -5.72 | 1,450 |
| 2021Q2 | 78.44 | 1,073 | -5.57 | -61 | -3.97 | 1,510 |
| 2021Q1 | 57.10 | 1,105 | -6.21 | -70 | -4.44 | 1,548 |